Indian hospital stocks reportedly fall amid Supreme Court scrutiny of drug markups
A September 30 post put Max Health and Apollo Hospitals down 5%, Fortis down 4.5% and Aster DM down 4%. It said the court questioned private hospitals’ medicine markups and requirements that inpatients buy from in-house pharmacies.
TLDR
Posts on September 30 described declines in Indian hospital stocks following Supreme Court remarks about private hospital pharmacy markups. One post said the court cited a cancer drug with a PTR of roughly ₹2,700 and an MRP of roughly ₹27,000. It said the court asked whether the existing 16% margin cap for scheduled drugs could extend to all medicines, but had not ordered such a cap. The post said the government sought time for consultations and the next hearing was scheduled for October 12, 2026. Another post argued that high treatment bills raise a broader affordability concern.
Combined views
51.7K
3 Sources, first seen 3h ago